Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Depression: Overview01:18

Depression: Overview

242
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
242

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Applying Artificial Intelligence and machine learning in precision nutrition.

Nature communications·2026
Same author

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same author

Exploring the needs of technical developers and stakeholders in point-of-care technology development: a qualitative study.

BMJ open·2026
Same author

Oral anticoagulant switching in patients with atrial fibrillation: a long-term cohort study using population-level administrative data.

International journal of clinical pharmacy·2026
Same author

Integrated triplex LFIA platform for decentralized molecular subtyping of breast cancer.

RSC advances·2026
Same author

Intestinal ultrasound reliably predicts fecal loading in patients with ulcerative colitis.

Journal of Crohn's & colitis·2026

相关实验视频

Updated: Jun 29, 2025

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
08:42

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression

Published on: May 19, 2015

10.6K

一个加拿大模拟模型主要抑郁障碍:研究协议.

Shahzad Ghanbarian1,2, Gavin W K Wong3,4, Mary Bunka3,4

  • 1School for Population and Public Health, University of British Columbia, Vancouver, BC, Canada. shahzad.ghanbarian@ubc.ca.

PharmacoEconomics - open
|March 26, 2024
PubMed
概括

药基因组 (PGx) 测试可以改善主要抑郁症 (MDD) 治疗结果,并降低医疗保健成本. 这项研究开发了一个模拟模型 (SiMMDep) 来评估PGx测试.

更多相关视频

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

相关实验视频

Last Updated: Jun 29, 2025

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
08:42

Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression

Published on: May 19, 2015

10.6K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K

科学领域:

  • 卫生经济学 卫生经济学
  • 药物基因组学 药物基因组学
  • 计算建模计算建模

背景情况:

  • 重度抑郁症 (MDD) 是一种普遍存在的疾病,医疗费用很高.
  • 目前的治疗方法通常需要进行多种药物试验,从而影响患者的生活质量.
  • 需要改进干预措施,以提高缓解率和减少经济负担.

研究的目的:

  • 开发一种经济模拟模型 (SiMMDep) 用于评估MDD治疗中的药基因组 (PGx) 测试.
  • 模拟MDD患者的患者护理途径.
  • 评估PGx测试的有效性和成本效益.

主要方法:

  • 在不列颠哥伦比亚省开发了MDD临床途径的离散时间微显模拟模型 (SiMMDep).
  • 纳入公共资助的治疗,多个治疗步骤和患者数据.
  • 利用模块化编码来实现灵活性,填充行政数据,系统审查和专家意见.
  • 通过面部,内部和交叉有效性检查验证模型.

主要成果:

  • SiMMDep从卫生系统的角度预测健康结果和成本.
  • 该模型可以模拟PGx引导治疗与标准护理.
  • 它估计了PGx测试的有效性,成本效益,资源利用率和健康益处.

结论:

  • SiMMDep是加拿大第一个针对MDD治疗的药物特定模拟模型,在患者的投入下开发.
  • 它合成数据来预测PGx测试的好处和成本.
  • 该模型的灵活基础设施可以支持政策问题和改善抑郁症护理效率.